Publication for AFM and KNG1
| Species | Symbol | Function* | Entrez Gene ID* | Other ID | Gene coexpression |
CoexViewer |
|---|---|---|---|---|---|---|
| hsa | AFM | afamin | 173 | [link] | ||
| hsa | KNG1 | kininogen 1 | 3827 |
| Pubmed ID | Priority | Text |
|---|---|---|
| 23849470 | 0.97 | AFM, GELS, KNG1, CATA and S10A9 (BMP/HR: Bone Marrow Plasma/High Risk, BMC: Bone Marrow Cells, PBC: Peripheral Blood Cells, PBP/HR: Peripheral Blood Plasma/High Risk, PBP/LR: Peripheral Blood Plasma/Low Risk, BMP/LR: Bone Marrow Plasma/Low Risk, ALL: Acute Lymphoblastic Leukemia). |
| 0.95 | AFM and KNG1 (Additional file 3: Figure S5). | |
| 0.89 | kininogen-1 (KNG1) were found overexpressed, whilst S10A9 and afamin (AFAM) were significantly down-regulated. | |
| 20501940 | 0.65 | kininogen-1 (KNG1), afamin (AFM), serine protease inhibitor (SERPINA5), LCAT, and sex hormone-binding globulin (SHBG)) in patients with rejection compared with those without rejection. |
The preparation time of this page was 0.0 [sec].
